SCHEMBL17920190

SCHEMBL17920190

CC1[C@H](C)CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10274078 1.00 — —
SCHEMBL4683316 1.00 — —
SCHEMBL15185118 1.00 — —
SCHEMBL15185117 1.00 — —
SCHEMBL15832400 1.00 — —
SCHEMBL22142580 1.00 — —
SCHEMBL9943073 0.82 — —
SCHEMBL22141994 0.82 — —
SCHEMBL22141993 0.82 — —
SCHEMBL22142219 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125825-A1 ANTICORONVIRAL COMPOUNDS AND COMPOSITIONS AND USES THEREOF SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD. (CN) 2023-07-06 — — WO disclosed
US-9758480-B2 1-(cycloalkyl-carbonyl)proline derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2017-09-12 — — US disclosed
US-20160200767-A1 CYCLOSPORIN DERIVATIVES WHEREIN THE MEBMT SIDECHAIN HAS BEEN CYCLIZED ALLERGAN, INC. 2016-07-14 — — US disclosed
Send feedback